AngioDynamics (ANGO) Misses Q3 EPS by 2c
Tweet
Share
E-mailGet Alerts ANGO Hot Sheet
Price: $15.55 +0.84%
Revenue Growth %: +6.3%
Financial Fact:
Cost of sales: 43.07M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Revenue Growth %: +6.3%
Financial Fact:
Cost of sales: 43.07M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
AngioDynamics (NASDAQ: ANGO) reported Q3 EPS of ($0.16), $0.02 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $66 million versus the consensus estimate of $75.73 million.
GUIDANCE:
AngioDynamics sees FY2024 EPS of ($0.54)-($0.58), versus the consensus of ($0.43). AngioDynamics sees FY2024 revenue of $270-275 million, versus the consensus of $312.1 million.
For earnings history and earnings-related data on AngioDynamics (ANGO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MillerKnoll, Inc. (MLKN) Tops Q1 EPS by 18c ; Offers Guidance
- AnaptysBio, Inc. (ANAB) Tops Q2 EPS by 524c
- ’Not your father’s Sandisk’: Rosenblatt starts coverage at Buy
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
